Vaneltix Pharma, Inc.
Clinical trials sponsored by Vaneltix Pharma, Inc., explained in plain language.
-
New bladder pain relief treatment enters Mid-Stage testing
Symptom relief Recruiting nowThis study is testing a single-dose bladder treatment called VNX001 to see if it can safely reduce sudden, moderate-to-severe bladder pain in people with interstitial cystitis/bladder pain syndrome. About 120 participants will receive either VNX001, a placebo (inactive solution),…
Phase: PHASE2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
New bladder pain treatment shows promise in clinical trial
Symptom relief Recruiting nowThis study is testing an experimental treatment called VNX001 for people with interstitial cystitis who experience sudden, severe bladder pain. The treatment is delivered directly into the bladder through a catheter when pain flares up. Researchers want to see how well it reduces…
Phase: PHASE2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated Mar 09, 2026 14:25 UTC